ACTRN12613001244796已完成未知
ong term follow up of the immunogenicity of 7-valent pneumococcal conjugate vaccine (PCV-7) vs 23-valent pneumococcal polysaccharide vaccine (23vPPV) PPV in vulnerable elderly populations at high risk for invasive pneumococcal disease
The Children's Hospital at Westmead. National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases0 个研究点目标入组 136 人开始时间: 2013年11月13日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 136
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 65 Years 至 o limit（—）
- 性别
- All
入选标准
- •Surviving subjects from the community who have previously participated in a completed trial of pneumococcal vaccines in frail elderly people when they were admitted to Westmead hospital between 2005-2007( Trial registration number ACTRN12607000387426)
排除标准
- •Not being able or refuse to provide a blood sample
研究者
相似试验
进行中（未招募）
1 期
ong-term follow-up study of immune response to vaccinations with RV001 in patients enrolled in RhoVac-001 studyProstate cancerEUCTR2020-004705-31-DKRhoVac ApS22
进行中（未招募）
1 期
A Long-Term Safety and Immunogenicity Follow-up of Healthy Adults Vaccinated with One Dose of Smallpox Vaccine (LISTER Strain).Five year follow-up of healthy adults already vaccinated in a previous trialEUCTR2006-000715-19-FRSanofi Pasteur SA230
进行中（未招募）
不适用
Follow-up study to evaluate the long-term immunogenicity and safety ofGlaxoSmithKline Biologicals' HPV (580299) vaccine in healthy femalesubjects.EUCTR2009-011357-41-DEGlaxoSmithKline Biologicals667
进行中（未招募）
不适用
A long-term, open, follow-up of the immunogenicity and safety of GlaxoSmithKline Biologicals’ HPV-16/18 L1 VLP AS04 vaccine in healthy female subjects up to 10 years after administration of the first vaccine dose in study HPV 014. - HPV-060 EXT 014 Y5-10For active immunization of women from the age of 10 years onwards to prevent cervical cancer (squamous-cell carcinoma and adenocarcinoma) by protecting against incident and persistent infections, cytological abnormalities including atypical squamous cells of undetermined significance (ASC US) and cervical intraepithelial neoplasia (CIN), CIN1 and pre-cancerous lesions (CIN2 and CIN3), caused by oncogenic human papillomavirus (HPV) types 16 and 18.EUCTR2009-011357-41-PLGlaxoSmithKline Biologicals667
已完成
不适用
Immunological characterization of TLR-7 mediated inflammation and complement activation after prolonged Imiquimod exposure in healthy volunteerscomplement activationInflammation1002766510014982NL-OMON51378Centre for Human Drug Research10